Odense, Denmark
Fri 07 14:30
MTE2.1
Sun 09 08:00
MTE2.2
London, UK
Sun 09 15:25
S9.1
Novel insights and long term outcomes
Unknown speaker
London, UK
Slovenia
Denmark
Sat 08 15:25
S6.3
Florence, Italy
Sun 09 08:00
MTE5.2
Australia
Sat 08 17:10
CON1.1
Solna, Sweden
Fri 07 12:15
S3.2
Growth plate: new insights in the origin and function of the growth plate
Solna, Sweden
Cambridge, UK
London, UK
Sun 09 16:25
S11.3
A laparoscopic approach in patients with Congenital Hyperinsulinism
London, UK
Philadelphia, USA
Sun 09 15:55
S11.2
Novel therapies in the treatment of Congenital Hyperinsulinism
Philadelphia, USA
France
London, UK
UK
Fri 07 16:25
PL2
From the 100,000 Genomes Project to a new NHS genomic medicine service
UK
Cambridge, UK
Sun 09 12:10
PL7
Novel insights into weight regulation
Cambridge, UK
UK
Sun 09 15:25
S11.1
Defining genotype-phenotype correlations in Congenital Hyperinsulinism
UK
UK
Sat 08 15:25
S10.1
The role of the MAPK pathway in hypothalamo-pituitary axis development and disease
UK
France
Fri 07 12:45
S5.3
Role of Epigenetics in endocrine disruption of prenatal development
France
USA
Sun 09 11:10
PL6
The current state of epigenetic research in humans: promise and reality
USA
London, UK
Sat 08 15:55
S10.2
Delayed puberty: A genetic condition?
London, UK
Bergen, Norway
USA
Sun 09 14:55
S7.2
Proton-beam Therapy for CNS tumours in childhood
USA
Denmark
Sun 09 15:55
S9.2
Testis function and fertility issues in men with CAH
Denmark
USA
Berlin, Germany
Sat 08 14:25
S8.1
Setmelanotide in the treatment of rare obesity syndromes
Berlin, Germany
London, UK
Fri 07 11:45
S4.1
Prophylactic thyroidectomy in Multiple Endocrine Neoplasia
Unknown speaker
London, UK
Cagliari, Italy
Sun 09 13:55
CON2.1
Should children with GHD be re-tested early eg as they start puberty, rather than wait until the final height is achieved? (FOR)
Cagliari, Italy
USA
Fri 07 11:45
S3.1
Epigenetic regulation of the growth plate
USA
Florence, Italy
Sat 08 08:40
MTE5.1
Italy
Sat 08 16:25
S10.3
Novel insights into the management of cranial diabetes and insipidus
Italy
UK
Sun 09 14:25
S7.1
Paediatric Neurosurgery in the 21st Century
UK
Edinburgh, UK
Sun 09 15:55
S12.2
Open APS – DIY closed loop systems
Edinburgh, UK
Dubai , UAE
Sun 09 09:10
HDI2.1
Munich, Germany
Sun 09 15:25
S7.3
Hypothalamic obesity in craniopharyngiomac
Munich, Germany
USA
Fri 07 12:15
S1.2
Pheochromocytomas and paragangliomas: from genetic diversity to targeted therapies
USA
Poland
Copenhagen , Denmark
Fri 07 15:30
HDI1.3
Israel
Sun 09 16:25
S12.3
The use of big data and artificial intelligence in managing the therapy of people with T1DM
Israel
Paris, France
Fri 07 12:45
S4.3
Congenital hypothyroidism ERN guidelines
Paris, France
Munich, Germany
Fri 07 11:45
S1.1
Pathogenesis of familial and sporadic hyperaldosteronism: new concepts involving Ion channels
Munich, Germany
Germany
Sun 09 17:15
PL8
The long-term effects of adolescent obesity
Germany
UK
Fri 07 11:45
S5.1
UK
Fri 07 12:45
S2.3
Calciotropic and non-calciotropic roles of the calcium sensing receptor
UK
Aarhus, Denmark
Fri 07 17:10
MTE3.1
Sun 09 08:00
MTE3.2
USA
Fri 07 12:45
S3.3
The osteocyte: translating biomechanics into endocrine signals
USA
USA
Melbourne, Australia
Sat 08 14:55
S8.2
Sweden
Italy
Asola, Italy
Cambridge, UK
Fri 07 12:15
S4.2
Novel genes implicated in thyroid dysfunction
Cambridge, UK
New Haven, USA
Sat 08 15:25
S8.3
Coming soon: new drugs for treatment of youth with type 2 diabetes
New Haven, USA
UK
Fri 07 12:15
S5.2
Turku, Finland
Fri 07 15:00
HDI1.2
USA
Germany
Sat 08 12:05
PL4
Development of novel therapies for obesity
Germany
Austria
Fri 07 12:15
S2.2
Phosphate toxicity: focus on medial vascular calcification
Austria
Ontario , Canada
Sat 08 08:40
MTE7.1
Ontario , Canada
Sun 09 14:00
MTE7.2
Kfar Saba, Israel
UK
Sun 09 15:25
S12.1
Latest developments in closed loop technology
UK
Leiden, The Netherlands
Sun 09 13:55
CON2.2
Should children with GHD be re-tested early eg as they start puberty, rather than wait until the final height is achieved? (AGAINST)
Leiden, The Netherlands
Germany
Sun 09 16:25
S9.3
Advances in the measurement of steroid hormones
Germany
New York, USA
Fri 07 12:45
S1.3
Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11β-hydroxysteroid dehydrogenase type 2 deficiency
New York, USA
USA
Sat 08 14:55
S6.2
New insights into sex differentiation and their clinical relevance to disorders of sex development
USA
Zurich, Switzerland
Sat 08 08:00
PL3
Iodine deficiency: A public health issue
Zurich, Switzerland
Workshop
3
Oral
28
Expert
25
Plenary
8
Catering and Social
9
Nurse
0
Other
22
Symposium
12
No Session Type
3
Sun 09 13:55
CON2.1
Should children with GHD be re-tested early eg as they start puberty, rather than wait until the final height is achieved? (FOR)
Cagliari, Italy
Sun 09 13:55
CON2.2
Should children with GHD be re-tested early eg as they start puberty, rather than wait until the final height is achieved? (AGAINST)
Leiden, The Netherlands
Fri 07 14:30
MTE2.1
Fri 07 17:10
MTE3.1
Sat 08 08:40
MTE5.1
Sat 08 08:40
MTE7.1
Sun 09 08:00
MTE2.2
Sun 09 08:00
MTE3.2
Sun 09 08:00
MTE5.2
Sun 09 14:00
MTE7.2
Fri 07 16:25
PL2
From the 100,000 Genomes Project to a new NHS genomic medicine service
UK
Sat 08 08:00
PL3
Iodine deficiency: A public health issue
Zurich, Switzerland
Sat 08 12:05
PL4
Development of novel therapies for obesity
Germany
Sun 09 11:10
PL6
The current state of epigenetic research in humans: promise and reality
USA
Sun 09 12:10
PL7
Novel insights into weight regulation
Cambridge, UK
Sun 09 17:15
PL8
The long-term effects of adolescent obesity
Germany
Fri 07 11:45
S1.1
Pathogenesis of familial and sporadic hyperaldosteronism: new concepts involving Ion channels
Munich, Germany
Fri 07 12:15
S1.2
Pheochromocytomas and paragangliomas: from genetic diversity to targeted therapies
USA
Fri 07 12:45
S1.3
Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11β-hydroxysteroid dehydrogenase type 2 deficiency
New York, USA
Fri 07 12:15
S2.2
Phosphate toxicity: focus on medial vascular calcification
Austria
Fri 07 12:45
S2.3
Calciotropic and non-calciotropic roles of the calcium sensing receptor
UK
Fri 07 11:45
S3.1
Epigenetic regulation of the growth plate
USA
Fri 07 12:15
S3.2
Growth plate: new insights in the origin and function of the growth plate
Solna, Sweden
Fri 07 12:45
S3.3
The osteocyte: translating biomechanics into endocrine signals
USA
Fri 07 11:45
S4.1
Prophylactic thyroidectomy in Multiple Endocrine Neoplasia
Unknown speaker
London, UK
Fri 07 12:15
S4.2
Novel genes implicated in thyroid dysfunction
Cambridge, UK
Fri 07 12:45
S4.3
Congenital hypothyroidism ERN guidelines
Paris, France
Fri 07 11:45
S5.1
Fri 07 12:15
S5.2
Fri 07 12:45
S5.3
Role of Epigenetics in endocrine disruption of prenatal development
France
Sat 08 14:55
S6.2
New insights into sex differentiation and their clinical relevance to disorders of sex development
USA
Sat 08 15:25
S6.3
Sat 08 14:25
S8.1
Setmelanotide in the treatment of rare obesity syndromes
Berlin, Germany
Sat 08 14:55
S8.2
Sat 08 15:25
S8.3
Coming soon: new drugs for treatment of youth with type 2 diabetes
New Haven, USA
Sat 08 15:25
S10.1
The role of the MAPK pathway in hypothalamo-pituitary axis development and disease
UK
Sat 08 15:55
S10.2
Delayed puberty: A genetic condition?
London, UK
Sat 08 16:25
S10.3
Novel insights into the management of cranial diabetes and insipidus
Italy
Sun 09 15:25
S9.1
Novel insights and long term outcomes
Unknown speaker
London, UK
Sun 09 15:55
S9.2
Testis function and fertility issues in men with CAH
Denmark
Sun 09 16:25
S9.3
Advances in the measurement of steroid hormones
Germany
Sun 09 15:25
S11.1
Defining genotype-phenotype correlations in Congenital Hyperinsulinism
UK
Sun 09 15:55
S11.2
Novel therapies in the treatment of Congenital Hyperinsulinism
Philadelphia, USA
Sun 09 16:25
S11.3
A laparoscopic approach in patients with Congenital Hyperinsulinism
London, UK
Sun 09 15:25
S12.1
Latest developments in closed loop technology
UK
Sun 09 15:55
S12.2
Open APS – DIY closed loop systems
Edinburgh, UK
Sun 09 16:25
S12.3
The use of big data and artificial intelligence in managing the therapy of people with T1DM
Israel
Sun 09 14:25
S7.1
Paediatric Neurosurgery in the 21st Century
UK
Sun 09 14:55
S7.2
Proton-beam Therapy for CNS tumours in childhood
USA
Sun 09 15:25
S7.3
Hypothalamic obesity in craniopharyngiomac
Munich, Germany
0 result(s) found.